Skip to content

Establishing the remote practice of pharmacy, requiring certain conditions for such practice and limiting activities performed under such practice, permitting a pharmacist to initiate therapy for certain conditions consistent with the pharmacist's education, training and experience, adding pharmacists who initiate such therapy to the healthcare stabilization fund and allowing a pharmacist to dispense a one-time emergency refill of a noncontrolled prescription drug for up to a 90-day supply when no refills remain, adopting compounding standards established by the United States pharmacopeia and allowing for exemptions from such standards and removing the authority of the state board of pharmacy to authorize individuals to access the prescription monitoring program database by rules and regulations.

It became law on Apr 9, 2026.

KS HB 2068 · House Bill · 2025-2026

Stage
Became law
Started in
House
Sponsor
1
Latest action
Apr 9, 2026

Where it stands

  1. Introduced (Done)

  2. Committee (Done)

  3. Floor (Done)

  4. Law (Done)

    Apr 9, 2026

This bill passed and is now law.

Read the full text

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

Once a bill is decided, the questions are about what is done with it in Kansas.

Work with this bill

Establishing the remote practice of pharmacy, requiring certain conditions for such practice and limiting activities performed under such practice, permitting a pharmacist to initiate therapy for certain conditions consistent with the pharmacist's education, training and experience, adding pharmacists who initiate such therapy to the healthcare stabilization fund and allowing a pharmacist to dispense a one-time emergency refill of a noncontrolled prescription drug for up to a 90-day supply when no refills remain, adopting compounding standards established by the United States pharmacopeia and allowing for exemptions from such standards and removing the authority of the state board of pharmacy to authorize individuals to access the prescription monitoring program database by rules and regulations. | 52